WallStSmart
DERM

Journey Medical Corp

NASDAQ: DERM · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$5.15
+3.00% today

Updated 2026-04-30

Market cap
$171.27M
P/E ratio
P/S ratio
2.77x
EPS (TTM)
$-0.47
Dividend yield
52W range
$4 – $10
Volume
0.2M

Journey Medical Corp (DERM) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item201420152016201720182019202020212022202320242025
Revenue$7.30M$7.30M$22.59M$4.54M$42.34M$34.92M$44.53M$63.13M$73.67M$79.18M$56.13M$61.86M
Revenue growth (YoY)+0.0%+209.4%-79.9%+832.4%-17.5%+27.5%+41.8%+16.7%+7.5%-29.1%+10.2%
Cost of revenue$1.18M$10.53M$14.59M$32.08M$30.77M$26.66M$20.88M$25.18M
Gross profit$7.30M$7.30M$22.59M$4.54M$41.16M$24.39M$29.94M$31.05M$42.89M$52.52M$35.26M$36.68M
Gross margin100.0%100.0%100.0%100.0%97.2%69.8%67.2%49.2%58.2%66.3%62.8%59.3%
R&D$30.71M$66.83M$83.17M$104.41M$80.55M$0.00$16.56M$10.94M$7.54M$9.86M$480000.00
SG&A$8.29M$17.72M$30.04M$71.90M$172.58M$19.13M$22.09M$39.83M$59.47M$48.06M$40.20M$44.37M
Operating income$-31.70M$-79.77M$-90.62M$-300.33M$-213.98M$5.26M$7.85M$-34.88M$-27.52M$-2.07M$-13.68M$-8.17M
Operating margin-434.2%-1092.7%-401.3%-6613.7%-505.4%15.1%17.6%-55.2%-37.4%-2.6%-24.4%-13.2%
EBITDA$-31.64M$-78.80M$-87.42M$-294.78M$-205.54M$6.44M$9.28M$-32.77M$-23.18M$1.92M$-8.40M$-3.83M
EBITDA margin-433.5%-1079.5%-387.1%-6491.6%-485.5%18.4%20.8%-51.9%-31.5%2.4%-15.0%-6.2%
EBIT$-31.69M$-78.87M$-87.54M$-295.12M$-206.09M$5.23M$7.85M$-35.33M$-27.55M$-1.93M$-11.91M$-8.17M
Interest expense$153000.00$147000.00$1.54M$8.14M$15.64M$255000.00$698000.00$7.03M$2.02M$1.70M$2.70M$3.70M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-31.88M$-78.40M$-89.08M$-303.26M$-221.54M$3.63M$5.28M$-43.99M$-29.63M$-3.85M$-14.67M$-11.43M
Net income growth (YoY)-146.0%-13.6%-240.4%+26.9%+101.6%+45.7%-932.7%+32.7%+87.0%-280.8%+22.1%
Profit margin-436.6%-1074.0%-394.4%-6678.3%-523.3%10.4%11.9%-69.7%-40.2%-4.9%-26.1%-18.5%